Global Opioids Drug Market Forecast 2019-2027

Wednesday, December 5, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Dec. 4, 2018 /PRNewswire/ -- KEY FINDINGSThe global opioids drugs market is anticipated to grow at a CAGR

of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. Increasing case of road accidents & surgical procedures are the main drivers that are propagating the global market growth for opioids drugs.Download
the full report: MARKET INSIGHTSThe opioid drugs are commonly used for alleviating the post-operative pains caused by surgical procedures.Opioid drugs are approved by FDA in the United States with ADF labeling and are currently marketed in North America.The market is segmented by products and applications, out of which, the former's oxycodone sub-segment is estimated to hold the highest market share in 2018.Growing demand for palliative care that aims to improve the quality of life for the patient suffering from terminal illness by implementing the use of opioid drugs is further driving the said market's growth.The growing opioid addiction crisis is leading to submission of lawsuits against pharmaceuticals companies who are manufacturing the opioid drugs.REGIONAL INSIGHTSThe global market for opioid drugs is geographically segmented into four regions, namely, North America, Asia-Pacific, Europe and countries from the Rest of the World.The North American economy holds the largest share for the market by revenue in the forecast years.The recurrently increasing geriatric population who are prone to irreversible and incurable disorders and chronic diseases are further enhancing the demand for pain management treatments in the market. Investments from local, regional players in the development of abuse-deterrent morphine drug are attributing for a high growth rate of morphine drug in the region.COMPETITIVE INSIGHTSAcura Pharmaceuticals, Inc., Allergan PLC, BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd. are some of the key market players who are dominating the global opioids market.Companies mentioned1. ACURA PHARMACEUTICALS, INC.2. ALLERGAN PLC3. BIODELIVERY SCIENCES INTERNATIONAL, INC.4. CIPHER PHARMACEUTICALS INC.5. COLLEGIUM PHARMACEUTICAL, INC.6. DAIICHI SANKYO, INC.7. EGALET CORP.8. HIKMA PHARMACEUTICALS PLC9. INDIVIOR INC.10. INSYS THERAPEUTICS, INC.11. JANSSEN PHARMACEUTICALS, INC.12. JOHNSON & JOHNSON13. LANNETT CO. INC.14. LUPIN LTD.15. MYLAN NV16. PFIZER INC.17. PURDUE PHARMA LP18. SANOFI-AVENTIS S.A.19. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)20. TEVA PHARMACEUTICAL INDUSTRIES LTD.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store